4//SEC Filing
AQUINOX PHARMACEUTICALS, INC 4
Accession 0001209191-16-135762
$NGNECIK 0001404644operating
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 6:23 PM ET
Size
5.9 KB
Accession
0001209191-16-135762
Insider Transaction Report
Form 4
Jenkins Abigail
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-08-03+50,000→ 50,000 totalExercise: $8.97Exp: 2026-08-02→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable at a rate of twenty-five percent of the total number of shares underlying the options on the one-year anniversary of the vesting commencement date and 1/48th of the total number of shares underlying the options each monthly anniversary of the vesting commencement date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total number of shares underlying the options shall be fully vested on the four-year anniversary of the vesting commencement date.
Documents
Issuer
AQUINOX PHARMACEUTICALS, INC
CIK 0001404644
Entity typeoperating
Related Parties
1- filerCIK 0001404644
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 6:23 PM ET
- Size
- 5.9 KB